Show simple item record

Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

dc.contributor.authorOzbalak, Murat
dc.contributor.authorAkay, Olga Meltem
dc.contributor.authorPehlivan, Mustafa
dc.contributor.authorYildiz, Birol
dc.contributor.authorUzay, Ant
dc.contributor.authorYigenoglu, Tugce Nur
dc.contributor.authorElverdi, Tugrul
dc.contributor.authorKaynar, Leylagul
dc.contributor.authorAyyildiz, Orhan
dc.contributor.authorHindilerden, Ipek Yonal
dc.contributor.authorGoksoy, Hasan Sami
dc.date.accessioned2021-12-21T08:47:58Z
dc.date.available2021-12-21T08:47:58Z
dc.date.issued2021
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2331
dc.language.isoEnglish
dc.publisherCıg Medıa Group, Lp
dc.titleBrentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
dc.typeMeeting Abstract
dc.relation.journalClınıcal Lymphoma Myeloma & Leukemıa
dc.identifier.startpageS368
dc.identifier.endpageS369
dc.identifier.volume21
dc.relation.volume21


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record